Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Sodium-Glucose Transporter 2 Inhibitors MeSH Descriptor Data 2026


MeSH Heading
Sodium-Glucose Transporter 2 Inhibitors
Tree Number(s)
D27.505.519.936
D27.505.696.422.750
Unique ID
D000077203
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077203
Scope Note
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.
Entry Term(s)
Gliflozin
Gliflozins
SGLT-2 Inhibitor
SGLT-2 Inhibitors
SGLT2 Inhibitor
SGLT2 Inhibitors
Sodium-Glucose Transporter 2 Inhibitor
Registry Numbers
0
Public MeSH Note
2019
History Note
2019
Date Introduced
2019/01/01
Last Updated
2021/06/30
Sodium-Glucose Transporter 2 Inhibitors Preferred
page delivered in 0.172s